<code id='87E2F98349'></code><style id='87E2F98349'></style>
    • <acronym id='87E2F98349'></acronym>
      <center id='87E2F98349'><center id='87E2F98349'><tfoot id='87E2F98349'></tfoot></center><abbr id='87E2F98349'><dir id='87E2F98349'><tfoot id='87E2F98349'></tfoot><noframes id='87E2F98349'>

    • <optgroup id='87E2F98349'><strike id='87E2F98349'><sup id='87E2F98349'></sup></strike><code id='87E2F98349'></code></optgroup>
        1. <b id='87E2F98349'><label id='87E2F98349'><select id='87E2F98349'><dt id='87E2F98349'><span id='87E2F98349'></span></dt></select></label></b><u id='87E2F98349'></u>
          <i id='87E2F98349'><strike id='87E2F98349'><tt id='87E2F98349'><pre id='87E2F98349'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:6
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

          Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

          advertisement

          MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Brazil's Jair Bolsonaro is barred from running for office until 2030
          Brazil's Jair Bolsonaro is barred from running for office until 2030

          MinisteroftheSupremeElectoralCourtCarmenLucia,right,talkswithCorregidorandMinisterRapporteurBenedito

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Belarusian journalist sentenced to 4 years in prison as crackdown continues

          TALLINN,Estonia--ABelarusianjournalistwassentencedFridaytofouryearsinprisonafterbeingconvictedofaidi